Protective effects of zinc in indomethacin-induced gastric mucosal injury: Evidence for a dual mechanism involving lipid peroxidation and nitric oxide

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 2, 1999, Pages 203-208

  Joseph, R M ^a   Varela, V ^a   Kanji, V K ^a   Subramony, C ^a   Mihas, A A ^a,b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; LIPID; MALONALDEHYDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ZINC; ZINC SULFATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; INTRAGASTRIC DRUG ADMINISTRATION; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH LESION; STOMACH MUCOSA; STOMACH PROTECTION; STOMACH ULCER;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; GASTRIC MUCOSA; INDOMETHACIN; LIPID PEROXIDATION; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, SPRAGUE-DAWLEY; ZINC;

EID: 0032993565     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00456.x     Document Type: Article

References (36)

1. Fries JF, Miller SR, Spitz PW, Williams CA, Hubert HB, Bloch DA. Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use. Gastroenterology 1989; 96: 647-55.
2. Whittle BJR. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 1981; 80: 94-8.
3. 2. Prostaglandins 1985; 30: 609-18.
4. Rainsford KD, Willis C. Relationship of gastric mucosal damage induced in pigs by antiinflammatory drugs to their effects on prostaglandin production. Dig Dis Sci 1982; 27: 624-35.
5. Ligumsky M, Golanska EM, Hansen DG, Kauffman GL. Aspirin can inhibit gastric mucosal cyclo-oxygenase without causing lesions in rats. Gastroenterology 1983; 84: 756-61.
6. Takeuchi K, Okada M, Ebara S, Osano H. Increased microvascular permeability and lesion formation during gastric hypermotilily caused by indomethacin and 2-deoxy-D-glucose in the rat. J Clin Gastroenterol 1990; 12(Suppl. 1): S76-S84.
7. Takeuchi K, Ueshima K, Hironaka Y, Fujioka Y, Matsumoto J, Okabe S. Oxygen free radicals and lipid peroxidation in the pathogenesis of gastric mucosal lesions induced by indomethacin in rats. Digestion 1991; 49: 175-84.
8. Yoshikawa T, Naito Y, Kishi A, et al. Role of active oxygen, lipid peroxidation, and antioxidants in the pathogenesis of gastric mucosal injury induced by indomethacin in rats. Gut 1993; 84: 732-7.
9. Naito Y, Toshikazu Y, Kaneko T, et al. Role of oxygen radicals in indomethacin-induced gastric mucosal microvascular injury in rats. J Clin Gastroenterol 1993; 17(Suppl. 1): S99-S103.
10. Vaananen PM, Meddings JB, Wallace JL. Role of oxygen-derived free radicals in indomethacin-induced gastric injury. Am J Physiol 1991; 261: G470-G475.
11. Wallace JL, Keenan CM, Granger DN. Gastric ulceration induced by nonsteroidal ant-inflammatory drugs is a neutrophil-dependent process. Am J Physiol 1990; 259: G462-7.
12. Santucci L, Fiorucci S, Giansanti M, Brunori PM, Di Matteo FM, Morelli A. Pentoxifylline prevents indomethacin induced acute gastric mucosal damage in rats: role of tumour necrosis factor alpha. Gut 1994; 35: 909-15.
13. McCarthy DM, Mechanisms of mucosal injury and healing: the role of non-steroidal anti-inflammatory drugs. Scand J Gastroenterol 1995; 30(Suppl. 208): 24-9.
14. Wallace JL. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology 1997; 112: 1000-16.
15. Cho CH. Current viewes of zinc as a gastrohepatic protective agent. Drug Develop Res 1989; 17: 185-97.
16. Rainsford KD, Whitehouse MW. Anti-ulcer activity of a slow release zinc complex, zinc monoglycerolate (glyzinc). J Pharm Pharmacol 1992; 44: 476-82.
17. Bulbena O, Escolar G, Navarro C, Bravo L, Pfeiffer CJ. Gastroprotective effect of zinc acexamate against damage induced by nonsteroidal antiinflammatory drugs - A morphological study. Dig Dis Sci 1993; 38: 730-9.
18. 2 production with different non-steroidal anti-inflammatory drugs: Modifications induced by pretreatment with zinc acexamate. Prostaglandins Leukot Essent Fatty Acids 1994; 50: 305-10.
19. de Rodriguez la Serna A, Diaz-Rubio M. Multicenter clinical trial of zinc acexamate in the prevention of nonsteroidal antiinflammatory drug induced gastroenteropathy. J Rheumatol 1994; 21: 927-33.
20. Pfeiffer CJ, Bulbena O, Esplugues JV, Escolar G, Navarro C, Esplugues J. Anti-ulcer and membrane stabilizing actions of zinc acexamate. Arch Int Pharmacodyn 1987; 285: 148-57.
21. Bulbena O, Esplugues JV, Escolar G, Navarro C, Esplugues J. Effects of zinc acexamate on blood flow and prostanoid levels in the gastric mucosa of the rat. Prostaglandins Leukotrienes and Essential Fatty Acids 1989; 36: 119-23.
22. Esplugues JV, Bulbena O, Escolar G, Marti-Bonmati E, Esplugues J. Effects of zinc acexamate on gastric mucosal resistance factors. Eur J Pharmacol 1985; 109: 145-51.
23. Dupuy D, Szabo S. Protection by metals against ethanol-induced gastric mucosal injury in the rat. Gastroenterology 1986; 91: 966-74.
24. Mann NS, Mann SK, Brawn PN, Weaver B. Effect of zinc sulfate and acetylcysteine on experimental gastric ulcer: In vitro study. Digestion 1992; 53: 108-13.
25. MacNaughton WK, Cirino G, Wallace JL. Endothelium-derived relaxing factor (nitric oxide) has protective actions in the stomach. Life Sci 1989; 45: 1869-76.
26. Whittle BJR, Lopez-Belmonte J, Moncada S. Regulation of gastric mucosal integrity by endogenous nitric oxide: interactions with prostanoids and sensory neuropeptides in the rat. Br J Pharmacol 1990; 99(3): 607-11.
27. Peskar BM, Respondek M, Muller KM, Peskar BA. A role for nitric oxide in capsaicin-induced gastroprotection. Eur J Pharmacol 1991; 198: 113-14.
28. Whittle BJR, Boughton-Smith NK, Moncada S. Biosynthesis and role of the endothelium-derived vasodilator, nitric oxide, in the gastric mucosa. Ann NY Acad Sci 1992; 664: 126-39.
29. Konturek SJ, Brzozowski T, Majka J, et al. Inhibition of nitric oxide synthase delays healing of chronic gastric ulcers. Eur J Pharmacol 1993; 239: 215-17.
30. Konturek SJ, Brozozowski T, Majka J, et al. Nitric oxide in gastroprotection by sucralfate, mild irritant and nocloprost. Role of mucosal blood flow. Dig Dis Sci 1994; 39(3): 593-600.
31. Li XY, Chow CK. An improved method for the measurement of malondialdehyde in biological samples. Lipids 1994; 29: 73-5.
32. Knowles RG, Palacios M, Palmer RMJ. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylated cyclase. Proc Natl Acad Sci USA 1989; 86: 5159-62.
33. Bredt DS, Snyder SH. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 1989; 86: 9030-3.
34. El-Newihi HM, Kanji VK, Mihas AA. Activity of gastric mucosal nitric oxide synthase in portal hypertensive gastropathy. Am J Gastroenterol 1996; 91: 535-8.
35. Elliot SN, McKnight W, Cirino G, Wallace J. A nitric oxide-releasing nonsteroidal antiinflammatory drug accelerates gastric ulcer healing in rats. Gastroenterology 1995; 109: 524-30.
36. Hisanaga Y, Goto H, Tachi K, Hayakawa T, Sugiyama S. Implication of nitric oxide synthase activity in the genesis of water immersion stress-induced gastric lesions in rats: the protective effects of FK-506. Aliment Pharmacol Ther 1996; 10: 933-40.